Hedge Fund - Matrix Capital Management
Zentalis Pharmaceuticals Inc. (ZNTL)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $22,196,357 | 6.39% | 13,959,973 | $2.16 |
| 2 | 2024 - Q4 (2024-12-31) | $42,298,718 | 1.96% | 13,959,973 | $3.28 |
| 3 | 2024 - Q3 (2024-09-30) | $51,372,701 | 2.45% | 13,959,973 | $3.63 |
| 4 | 2024 - Q2 (2024-06-30) | $57,096,290 | 0.43% | 13,959,973 | $11.17 |
| 5 | 2024 - Q1 (2024-03-31) | $220,009,174 | 2.04% | 13,959,973 | $13.75 |
| 6 | 2023 - Q4 (2023-12-31) | $211,493,591 | 2.17% | 13,959,973 | $14.59 |
| 7 | 2023 - Q3 (2023-09-30) | $280,037,058 | 3.35% | 13,959,973 | $25.38 |
| 8 | 2023 - Q2 (2023-06-30) | $393,810,838 | 4.57% | 13,959,973 | $23.99 |
| 9 | 2023 - Q1 (2023-03-31) | $158,239,536 | 2.14% | 9,199,973 | $20.25 |
| 10 | 2022 - Q4 (2022-12-31) | $185,287,456 | 3.53% | 9,199,973 | $21.51 |
| 11 | 2022 - Q3 (2022-09-30) | $199,271,000 | 3.81% | 9,199,973 | $27.35 |
| 12 | 2022 - Q2 (2022-06-30) | $258,519,000 | 5.85% | 9,199,973 | $26.49 |
| 13 | 2022 - Q1 (2022-03-31) | $200,676,000 | 2.4% | 4,349,279 | $53.94 |
| 14 | 2021 - Q4 (2021-12-31) | $365,600,000 | 4.06% | 4,349,279 | $77.38 |
| 15 | 2021 - Q3 (2021-09-30) | $289,836,000 | 3.29% | 4,349,279 | $57.69 |
| 16 | 2021 - Q2 (2021-06-30) | $218,159,000 | 2.38% | 4,100,739 | $53.56 |
| 17 | 2021 - Q1 (2021-03-31) | $165,825,000 | 1.91% | 3,821,739 | $43.05 |
| 18 | 2020 - Q4 (2020-12-31) | $198,501,000 | 2.14% | 3,821,739 | $45.11 |
| 19 | 2020 - Q3 (2020-09-30) | $124,933,000 | 1.66% | 3,821,739 | $35.01 |
| 20 | 2020 - Q2 (2020-06-30) | $183,520,000 | 2.86% | 3,821,739 | $38.35 |
The displayed share prices are average quarterly stock market prices.